Skip to main content
The Globe and Mail
Support Quality Journalism
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); }
Coronavirus information
Coronavirus information
The Zero Canada Project provides resources to help you make the most of staying home.
Visit the hub

A Dyson logo is seen on one of company's products during an event in Beijing, China, in a Sept. 12, 2018, file photo.

Damir Sagolj/Reuters

Britain has ordered 10,000 medical ventilators designed at breakneck speed by vacuum cleaner-maker Dyson, billionaire founder James Dyson said, as the country tries to boost the number of devices available to treat coronavirus patients.

The government, in anticipation of cases peaking in Britain in coming weeks, had made an urgent appeal to manufacturers to supply the National Health Service and would also use devices from private hospitals and other sources.

“We have received an initial order of 10,000 units from the U.K. Government which we will supply on an open-book basis,” James Dyson said on Wednesday in an e-mail to staff seen by Reuters.

Story continues below advertisement

“We are also looking at ways of making it available internationally.”

The government did not comment on the Dyson e-mail.

Britain had been in talks with over 3,000 businesses about supplying ventilators to quickly increase the health service’s capacity, Prime Minister Boris Johnson’s spokesman said earlier on Wednesday.

But he stressed that any design would need regulatory approval.

The country’s existing stock of about 5,000-8,000 ventilators is inadequate if cases jump as predicted. The number of coronavirus deaths in Britain rose by 41 to 465 on Wednesday.

Dyson said since receiving a call from Johnson 10 days ago, he had refocused resources at his company, and worked with TTP, The Technology Partnership, to design and build an entirely new ventilator, The CoVent.

It deployed its expertise in air movement, motors, power systems, manufacturing and supply chain gained from its products like air purifiers and fans as well as cleaners to develop the ventilator from scratch.

Story continues below advertisement

The company, which revolutionized the vacuum cleaner market with its bagless cyclonic device in the 1990s, said it would work with regulators and government to ensure that the product and the manufacturing process was approved.

Dyson said it was “clearly a time of grave international crisis,” and he would therefore donate 5,000 units to the international effort, 1,000 of which would go to the United Kingdom.

Separately, British engineer Babcock International Group Plc said it had joined forces with a leading medical equipment company to design and supply thousands of critical care ventilators.

A number of other firms had joined forces to potentially develop and manufacture a ventilator, including Airbus, Smiths Group Plc, Ford Motor Co and McLaren.

Reuters had reported earlier that British industry expected the government to give the go-ahead for an emergency ventilator production plan on Wednesday.

The spread of the novel coronavirus that causes COVID-19 continues, with more cases diagnosed in Canada. The Globe offers the dos and don'ts to help slow or stop the spread of the virus in your community.

Sign up for the Coronavirus Update newsletter to read the day’s essential coronavirus news, features and explainers written by Globe reporters.

In the interests of public health and safety, our coronavirus news articles are free for anyone to access. However, The Globe depends on subscription revenue to support our journalism. If you are able, please subscribe to globeandmail.com. If you are already a subscriber, thank you for your support.

Your subscription helps The Globe and Mail provide readers with critical news at a critical time. Thank you for your continued support. We also hope you will share important coronavirus news articles with your friends and family. In the interest of public health and safety, all our coronavirus news articles are free for anyone to access.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies